Medtecs International Corporation Limited (9103.TW)
TWD 6.25
(1.3%)
TWD 6.25
(1.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.18 Million | -4.05 Million | 29.76 Million | 101.59 Million | 4.37 Million | 5.62 Million |
| Net Income | -22.51 Million | -30.65 Million | 16.91 Million | 135.09 Million | 1.51 Million | 1.18 Million |
| Depreciation & Amortization | 7.2 Million | 6.4 Million | 6.63 Million | 8.07 Million | 5.81 Million | 4.95 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.07 Million | 5.97 Million | 2.99 Million | -41.51 Million | -4.93 Million | -2.21 Million |
| Other non-cash items | 9.19 Million | 14.21 Million | 3.21 Million | -59 Thousand | 1.98 Million | 1.69 Million |
| Investing Cash Flow | 9.6 Million | -23.9 Million | -15.42 Million | -6.18 Million | -4.64 Million | -4.8 Million |
| Investments in PPE | -7.4 Million | -19.77 Million | -16.37 Million | -8.4 Million | -4.57 Million | -5.3 Million |
| Acquisitions | 3.93 Million | - | - | - | - | - |
| Investment purchases | 2.51 Million | -12.72 Million | - | - | - | - |
| Sales/Maturities of investments | 10.97 Million | - | - | - | - | - |
| Other Investing Activities | -408 Thousand | 8.59 Million | 952 Thousand | 2.21 Million | -77 Thousand | 502 Thousand |
| Financing Cash Flow | 1.84 Million | -2.96 Million | -47.48 Million | -16.31 Million | -1.17 Million | 1.97 Million |
| Debt repayment | -15.64 Million | -5.45 Million | -1.47 Million | -4.77 Million | -1.84 Million | -93 Thousand |
| Dividends payments | - | -3.27 Million | -22.84 Million | -4.66 Million | - | - |
| Common Stock Repurchased | - | -249 Thousand | -2.11 Million | - | - | - |
| Common Stock Issuance | - | 5.45 Million | -23.55 Million | - | - | - |
| Other Financing Activities | -4.54 Million | 559 Thousand | 2.5 Million | -6.86 Million | 669 Thousand | 2.06 Million |
| Accounts receivables | 86 Thousand | 7.89 Million | 6.5 Million | -33.99 Million | 1.55 Million | 25 Thousand |
| Accounts payables | -86 Thousand | -7.89 Million | -6.5 Million | 33.99 Million | -1.55 Million | -25 Thousand |
| Inventory | -2.59 Million | 886 Thousand | 640 Thousand | -15.14 Million | -4.16 Million | -152 Thousand |
| Other working capital | 1.43 Million | 5.09 Million | 2.35 Million | -26.36 Million | -776 Thousand | -2.05 Million |
| Cash at beginning of period | 18.12 Million | 49.01 Million | 82.16 Million | 3.07 Million | 4.52 Million | 1.73 Million |
| Cash at end of period | 22.3 Million | 18.12 Million | 49.01 Million | 82.16 Million | 3.07 Million | 4.52 Million |
| Capital Expenditure | -7.4 Million | -19.77 Million | -16.37 Million | -8.4 Million | -4.57 Million | -5.3 Million |
| Effect of forex changes on cash | -80 Thousand | 22 Thousand | -377 Thousand | - | - | - |
| Net cash flow / Change in cash | 4.18 Million | -30.89 Million | -33.14 Million | 79.09 Million | -1.45 Million | 2.79 Million |
| Free Cash Flow | -14.59 Million | -23.83 Million | 13.38 Million | 93.18 Million | -202 Thousand | 316 Thousand |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.87 Million | -22.51 Million | -15.7 Million | -5.35 Million | -30.65 Million | -24.89 Million |
| Depreciation & Amortization | 3.74 Million | 7.2 Million | 3.57 Million | 2.63 Million | 6.4 Million | 2.39 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.13 Million | -1.07 Million | 5.19 Million | -5.69 Million | 5.97 Million | 25.47 Million |
| Other non-cash items | -669 Thousand | 9.19 Million | 7.57 Million | 599 Thousand | 14.21 Million | 12.95 Million |
| Investing Cash Flow | -492 Thousand | 9.6 Million | 8.88 Million | 721 Thousand | -23.9 Million | -13.35 Million |
| Investments in PPE | -1.07 Million | -7.4 Million | -3.42 Million | -1.46 Million | -19.77 Million | -10.12 Million |
| Acquisitions | - | 3.93 Million | - | - | - | - |
| Investment purchases | - | 2.51 Million | - | - | -12.72 Million | - |
| Sales/Maturities of investments | - | 10.97 Million | - | - | - | - |
| Other Investing Activities | 584 Thousand | -408 Thousand | 12.31 Million | 2.18 Million | 8.59 Million | -3.22 Million |
| Financing Cash Flow | -2.23 Million | 1.84 Million | -2.32 Million | 4.16 Million | -2.96 Million | -23.92 Million |
| Debt repayment | -278 Thousand | -15.64 Million | - | -589 Thousand | -5.45 Million | - |
| Dividends payments | - | - | - | - | -3.27 Million | -237 Thousand |
| Common Stock Repurchased | - | - | - | - | -249 Thousand | - |
| Common Stock Issuance | - | - | - | - | 5.45 Million | - |
| Other Financing Activities | -1.95 Million | -4.54 Million | -2.32 Million | 4.74 Million | 559 Thousand | -23.69 Million |
| Accounts receivables | 826 Thousand | 86 Thousand | -1.52 Million | 1.68 Million | 7.89 Million | 6.04 Million |
| Accounts payables | - | -86 Thousand | - | - | -7.89 Million | - |
| Inventory | -1.23 Million | -2.59 Million | 903 Thousand | -3.49 Million | 886 Thousand | 672 Thousand |
| Other working capital | -723 Thousand | 1.43 Million | 5.82 Million | -3.88 Million | 5.09 Million | 18.75 Million |
| Cash at beginning of period | 22.3 Million | 18.12 Million | 15.18 Million | - | 49.01 Million | 39.46 Million |
| Cash at end of period | 17.63 Million | 22.3 Million | 22.3 Million | 15.18 Million | 18.12 Million | 18.12 Million |
| Capital Expenditure | -1.07 Million | -7.4 Million | -3.42 Million | -1.46 Million | -19.77 Million | -10.12 Million |
| Effect of forex changes on cash | - | -80 Thousand | -80 Thousand | 18.12 Million | 22 Thousand | 22 Thousand |
| Net cash flow / Change in cash | -4.66 Million | 4.18 Million | 7.12 Million | 15.18 Million | -30.89 Million | -21.34 Million |
| Free Cash Flow | -3.01 Million | -14.59 Million | -2.78 Million | -9.29 Million | -23.83 Million | 5.79 Million |
TDVXF
OKTA
MAXHEALTH
TORNTPOWER
OX2
MERCURYEV